Dalla pandemia al new normal, tra Covid e Long Covid

adnkronos

(Adnkronos) - Si è tenuto a Roma, presso il Palazzo dell’informazione di Adnkronos, l’evento “Dalla pandemia al new normal, tra Covid e Long Covid”, organizzato da HC Training. A tre anni di distanza dall'esplosione della pandemia, il sistema dell'informazione ha raggiunto un elevato livello di saturazione rispetto al tema Covid, nonostante gli studi e le ricerche medico-scientifiche siano tutt'ora in corso. L’obiettivo dell’evento, dedicato a giornalisti e professionisti nel mondo dell’informazione,  è stato quello far chiarezza sulle più recenti evoluzioni della ricerca in ambito clinico e scientifico focalizzandosi sulla attuale realtà del Covid e sulle conseguenze della patologia nel lungo periodo, il cosiddetto Long Covid.

Transcript

00:00 [Music]

00:04 The event "From the Pandemic to the New Normal" between COVID and Long COVID

00:08 was held in Rome at the ADN Kronos Information Palace,

00:12 organized by the HC Training.

00:15 Three years after the pandemic,

00:18 the information system has reached a high level of saturation

00:22 compared to the COVID theme,

00:24 despite the studies and medical-scientific research

00:27 that are still underway.

00:29 The aim of the event,

00:31 dedicated to journalists and professionals in the world of information,

00:34 was to clarify the most recent evolutions

00:37 in clinical and scientific research,

00:39 focusing on the current reality of COVID

00:42 and the consequences of the pathology in the long term,

00:45 the so-called Long COVID.

00:47 What we are observing now is the transition

00:50 to a phase of virus endemic,

00:53 which means that the virus circulates in the population

00:56 in a more or less regular way,

00:59 and will make us observe what we call

01:02 epidemic recurrences, that is, seasonal epidemics,

01:05 a bit like what happens with influenza.

01:08 It is difficult to say today when and with what cadence

01:11 these viral circulation cycles will occur,

01:15 but once again, science gives us the tools

01:18 to observe, monitor and obviously prevent,

01:21 thanks to vaccination.

01:23 For now, we are given an idea that this vaccination

01:26 will most likely be seasonal,

01:28 a bit like what happens with influenza,

01:31 but it is still not clear when it will be done.

01:34 We have to wait a few weeks

01:37 to see the progress of the virus in the next season.

01:40 After an analysis of the evolution of SARS-CoV-2 infection

01:43 and the clinical and therapeutic aspects,

01:46 the reporters focused on the symptoms and incidence

01:49 of Long COVID and the experiences of the fragile patients.

01:52 Despite the WHO declaring the end of the pandemic emergency,

01:56 the virus circulation imposes a constant

01:59 attention to the fragile patients.

02:02 Today COVID is no longer an emergency,

02:06 but we must not lower our guard,

02:09 especially for the patients we represent.

02:12 There are new drugs that have certainly

02:16 also given a turn to the fragile patients.

02:20 I am talking about monoclonal and antiviral drugs

02:23 that have given us a great help,

02:26 to us patients with immunodeficiency,

02:29 to overcome these obstacles.

02:32 The COVID issue continues to be relevant

02:35 from the point of view of national and international

02:38 health security, although it has often been a source

02:41 of divisions and polarizations.

02:43 The Institute of Piedmont, for example,

02:45 finds that even today, one in three Italians

02:47 believes that vaccines are experimental.

02:50 Experts agree on the impossibility of making predictions,

02:53 but at the same time we are faced with probable future scenarios.

02:57 Omicron has marked the definitive change of the infection,

03:01 linked to a lower pathogenicity and the spread of very,

03:07 very diffuse variants, but also very immune-evasive.

03:12 They tend not to be intercepted by the antibodies

03:16 that we have produced with the vaccine or with previous infections.

03:19 So what will be the future?

03:21 A series of micro-epidemic waves,

03:24 we will no longer have large waves, but micro-waves,

03:27 mini-waves, let's say, as the Americans call them,

03:30 in which we will have locally, and with a poor

03:33 ability to predict, the spread of the virus,

03:37 which will hit, however, quite robustly,

03:39 especially fragile and immunodepressed patients.

03:42 And on those, the attention of doctors and the scientific community

03:46 today will have to focus.

Category

Transcript

Recommended